Molecule Information
General Information of the Molecule (ID: Mol05871)
| Name |
SNHG16
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Molecule Type |
Long non-coding RNA
|
||||
| Sequence |
GCGTTCTTTTCGAGGTCGGCCGCGTGGCTGGAAGACATGGCCACTCCAGTCGGTGTTGAG
CACGGCGAGCAGTCTCAGGCCTTTAGTGATGATGATTAAAGGTGGTGGCTGTGGCCTTGA AAACAGTCATGTGAAAACTCATCACCTTAAGGTGTTAAGTGTAAGGATCTTCATGATGAA ATTTCTGTAAATGGTGCAGTCAGCCTCAGTTTCCAAAGCCGGAAAAGGATCCTCTAGTAG CCACGGTGTGGCAGCTGCTCTGAACCAGGACCTGGACCCGGACCCAAAGTGCCATGTCTT TAATGTGAGTTAGCTCCCAGCGATGCCAGATGGGATCAGCACAGCCCTGCCTCTGCTGCT AATTGTTCCTCTAAAGTAATCGCCATGCGTTCTTTGGGCTTCATCTTTAAAGGAATGAAG CAACTGAGATTATTCTGGAAAACCTTTTGGCAGTTAGTGAAATTAGAGTACAACTAAGAA CATTTTCAGACCTCCACTGTGGATGACCTGGGTATAATCTCACAAATCGATGGGACTGCA AGGATTGTAAACTGAAATGAACATGATTATACTCTGTTGGAAGAGCCTAAGAGGAAACTG ATGCCATGAGTTTCAGAGAGTAATGCTTAACCCCAGTTACACAGGATGCCGTCTTGTGTT TCCTCTTGTTTAGTTACCCACTACAGTGATTTTGTGATCTGCTAATGGGTTGCCACCCAC AACCATTGCTTTAGCACTTTTACTTCAAATCAATGAAGGATTGATAAAAGTTCTCCTGGT GTCTCCGCAGAGTGCCTTCCAGGAACAGATCTTTGCATAGAATATCAGTGGTTTCCTTTT TTGTTTCAAATAGTGGTCAGAAAATACCCAGTGTTGACTCACCAAGGCAATCAGCTTCCT TTTTCCCTTTTTTTGTTTTTTTTTTAACATTTTATATTTTTGCTTTATTTTATTTTATTT TATTTTATTTTATTTTATTTTATTTTATTTTTTGAGACGGAGTTCCACTCTGTCGCCAGG CTGGAGTGAAGTGGTACAATCTTGGCTCACTGCAACCTCCACCTCCCGGGTTCAAGCAAT TCTCCTGGCTCAGCCTCCTGAGTGCTGGGACTACAGGCGCGTACCTTCTTTAGTAGAGAC TGGGTTTCACCATGTTGGCCAGGATGGTCTCTATCTCCTGACCTTGTGATCTGCCTGCCT CAGCTTCCCAAAGTGCTGAGATGACAGGTGTGAGCCATCAGACCCAGCATTTTTTTTTTT AATTTAAATTTAAATTTTTTTTCATTTTTTTGAGAGGTTTTTTTTGTTTTGTTTTGTTGT TGTTGTTGTTGTTGTTTTTGAGACAGTCTTGCTCTGTCACCCAGGCTGGGAGTGCAGTGG CATGATCTCTGCAACCTCTACCTCCCAGGTTCAAGCAATTCTTGTGCCTCAGCCTCCCAA GTAACTGGGACTACAGGTGCACGCTACCACACCTGGCTGATTTTTTTTGTTTTAGTAGAG ACAGGGTTTCAACCATGTTGCCCAGGTTGGTCTCAAACTCCTGAGCTCAGGCAATCCACC CGCCTTGGCCTCCCAAAGTGCTAGGATTACAGGTGTGAGCCACCACACCCAGCTATTTTT TCTTTCGTTTTTTAATTTTAAAGTTGGGGGGGGGTCTCAATTTGTTACCCTGGCTGGTCT CGAACTCCCGGACTTAAGCGATCCTCTGGCTCCAAGCCCACTACCAGTCTCAGGTTTCTT TACTAAAAGATCACTACCTTTTTTTCTCTTATCTGCTGCCATGTGAGATGTGGCTTTCAC CTTCCGCCATGATTGTGAGGCCTTCCCAGCCATGTAGAACTGTAAGTCCAATAAACCTCT TTTGTAAATTAAAAAAAAAAAATCACTATTTAAGATACTAGGATGGATTGTGACTGTTGA GGAGTACTTACATATCCTACATTTGACTACATTATTTCCAAACCAAGTATTCCATCCAAA GGAACATACTGCTATCATAGAGACCAAGGAGGGACTGTTTAAGGTTGCCAAGGTGAAGCG AGCTGAGAGGCTTTGTCCTCGTGCCAGTAACTCTGAAATCTCTCTTAATTCCTGCTGTCC AGGCAGCAGAATGCCATGGTTTCCCCAAGTAGGTAGCTGCTTTAGCAGTTAAAGCCCAAA TGTCTGTTCTGTTGATCAGAGGTCTCTGAATTTCTGAAGTGGTGTTTCGTTTCTGGTGAC TGAGTTAATCCTTTACAATCCCTCTTGTAAAGTGTGCTAATAGAAAGAATCCACCTTTCA AAGCTGCAGAACCAGACCGTGCCCTAAATTGACCAACGTAACTGATGTGCCTCAGGAAGT CTCTTGCCAGCTGTCCCTGTGAAGACCCCCCTCCTCCCCCCCAGCTGCTGCCTTGCACAC TGAAGCATCTCAGACTGTGCAAAGCCGTGTAGTCATCAAGACAGTAAATCCCAGGGCTTG GTTAAGTGCTGTGTGATAACTTGTTTGGATGAGACTTAACTTAAAACCACTTACAATAAA CTTGGGAAACTACCGTCA Click to Show/Hide
|
||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Hepatocellular carcinoma [ICD-11: 2C12.0] | [1] | |||
| Sensitive Disease | Hepatocellular carcinoma [ICD-11: 2C12.0] | |||
| Sensitive Drug | Sorafenib | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | HL-7702 cells | Liver | Homo sapiens (Human) | CVCL_6926 |
| Skhep1 cells | Liver | Homo sapiens (Human) | CVCL_0525 | |
| Huh7 cells | Kidney | Homo sapiens (Human) | CVCL_U442 | |
| Hep3B cells | Liver | Homo sapiens (Human) | CVCL_0326 | |
| HepG2 cells | Liver | Homo sapiens (Human) | CVCL_0027 | |
| Experiment for Molecule Alteration |
qRT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | RESULTS We found that SNHG16 was upregulated in HCC tissues and cell lines and that it was negatively correlated with survival time in HCC patients. Univariate and multivariate analyses revealed that SNHG16 was a significant and independent predictor for the overall survival of HCC patients. Furthermore, downregulation of SNHG16 inhibited proliferation, migration, invasion, and sorafenib resistance in hepatocellular carcinoma cell lines. CONCLUSIONS Our findings revealed that lncRNA SNHG16 could be used as an oncogene to predict the outcome of hepatocellular carcinoma. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
